benzoxazoles has been researched along with Mitral Valve Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, H; Al-Hesayen, A; Asgar, AW; Chan, M; Cherney, D; Cohen, G; Cohen-Solal, A; D'Astous, M; Davis, M; De, S; Delgado, DH; Desplantie, O; Ducharme, A; Estrella-Holder, E; Ezekowitz, JA; Fine, N; Giannetti, N; Green, L; Grzeslo, A; Haddad, H; Harkness, K; Heckman, GA; Hernandez, AF; Howlett, JG; Koshman, SL; Kouz, S; LeBlanc, MH; Lee, D; Lepage, S; Masoudi, FA; Matteau, S; McDonald, M; McKelvie, RS; Mielniczuk, LM; Moe, GW; O'Meara, E; Parent, MC; Rajda, M; Ross, HJ; Sussex, B; Swiggum, E; Toma, M; Verma, S; Virani, SA; Zieroth, S | 1 |
1 other study(ies) available for benzoxazoles and Mitral Valve Insufficiency
| Article | Year |
|---|---|
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
Topics: Amyloidosis; Angiotensin Receptor Antagonists; Benzoxazoles; Heart Diseases; Heart Failure; Humans; Mitral Valve Insufficiency; Neprilysin; Randomized Controlled Trials as Topic; Severity of Illness Index; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume | 2020 |